The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Benzodiazepine Sensitivity in Panic Disorder: Effects of Chronic Alprazolam Treatment
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, another study reported tolerance to the acute amnesic effects of alprazolam after chronic use [40].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [40]
In the citing paper
“Also, other studies have shown that chronic users displayed no increase in sedation or motor impairment after the acute application of a benzodiazepine [38–40].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [40]
In the citing paper
“In support, plasma levels after acute diazepam administration did not differ between chronically alprazolam-treated and untreated panic disorder patients, even though sedative and amnesic tolerance was observed [40].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [40]
In the citing paper
“This was confirmed by another study in panic disorder patients who already chronically took alprazolam. Here, no differences were found in cortisol responsivity or anxiolytic efficacy compared to alprazolam-naïve patients, independent of disease severity [40].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [40]
Citations
Cites
The Neurology of Eye Movements
Leigh, R. J., & Zee, D. S. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199969289.001.0001 · Cited by 3,820
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Assessment of Depression: The Depression Inventory
Beck, A. T., & Beamesderfer, A. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395074 · Cited by 1,832
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
The main sequence, a tool for studying human eye movements
Bahill, A. T., Clark, M. R., & Stark, L. (1975) · Mathematical Biosciences · doi:10.1016/0025-5564(75)90075-9 · Cited by 1,285
Hikosaka, O., & Wurtz, R. H. (1985) · Journal of Neurophysiology · doi:10.1152/jn.1985.53.1.266 · Cited by 689
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Use of benzodiazepines in anxiety disorders
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281907 · Cited by 341
Self-citationAbuse liability of benzodiazepines.
Woods, J. H., Katz, J. L., & Winger, G. (1987) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06658-x · Cited by 315
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.250.6.767 · Cited by 276
Cited by
The Neuropsychology of Anxiety: An enquiry into the function of the septo-hippocampal system
Gray, J. A., & McNaughton, N. (2003) · doi:10.1093/acprof:oso/9780198522713.001.0001 · Cited by 1,928
The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
Penninx, B. W. J. H., Beekman, A. T. F., Smit, J. H., Zitman, F. G., Nolen, W. A., Spinhoven, P., Cuijpers, P., De Jong, P. J., Van Marwijk, H. W. J., Assendelft, W. J. J., et al. (2008) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.256 · Cited by 927
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
“In humans, for example, tolerance develops rapidly to sedative effects and motor coordination deficits; whereas tolerance does not always develop to the anxiolytic or memory impairing effects of benzodiazepine-type drugs after long periods of use (Cowley et al., 1995; Griffiths and Weerts, 1997; Stoops and Rush, 2003).”
BackgroundVinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“However, another study reported tolerance to the acute amnesic effects of alprazolam after chronic use [40].”
BackgroundInfluentialSundström, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., & Bäckström, T. (1998) · Neuroendocrinology · doi:10.1159/000054307 · Cited by 182
Deckersbach, T., Savage, C. R., Reilly‐Harrington, N., Clark, L., Sachs, G., & Rauch, S. L. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00118.x · Cited by 139
Skelton, K. H., Nemeroff, C. B., Knight, D. L., & Owens, M. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01240.2000 · Cited by 127
“These drugs have been demonstrated to suppress HPA axis activation (Krulik and Cerny, 1971; Kalogeras et al., 1990; Rorher et al., 1994; Cowley et al., 1995), to attenuate stress-induced CRF neuronal activation (c-fos mRNA), as well as the subsequent increase in CRF production (CRF mRNA) and release (Imaki et al.”
BackgroundSelf-citationThe GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.
Roy‐Byrne, P. (2005) · PubMed · Cited by 119
Self-citationThe Neuropsychology of Anxiety: An enquiry into the functions of the septo-hippocampal system
McNaughton, N., & Gray, J. A. (2024) · doi:10.1093/oso/9780198843313.001.0001 · Cited by 113
Gravielle, M. C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.030 · Cited by 87
Antiepileptic Drugs in the Treatment of Anxiety Disorders: Role in Therapy
Ameringen, M. V., Mancini, C., Pipe, B., & Bennett, M. (2004) · Drugs · doi:10.2165/00003495-200464190-00004 · Cited by 84
Fundamentals of the septo-hippocampal system
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0009 · Cited by 68
Cheng, T., Wallace, D. M., Ponteri, B. B., & Tuli, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164307 · Cited by 66
“Diazepam and alprazolam for the treatment of panic attacks, social phobia, and other anxiety-related disorders are effective even after chronic use.(90,91) Could this mean α 2 and α 3 containing GABA A receptors, which mediate anxiety, have less significance in the tolerance building mechanism of benzodiazepines? Othe…”
Pomara, N., Willoughby, L. M., Sidtis, J. J., Cooper, T. B., & Greenblatt, D. J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1974-8 · Cited by 61
“In contrast to other reports (Hommer et al. 1986; Cowley et al. 1995), we found no significant correlation between diazepam-induced cortisol reduction and the effect of diazepam on subjective ratings of mood states as well as more objective measure of cognitive performance that were also…”
ResultSelf-citationCentral Nervous System Depressants
Schuckit, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3232-0_2 · Cited by 53
Ferreri, M. C., Gutiérrez, M. L., & Gravielle, M. C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.038 · Cited by 48
Rezvanfard, M., Zarrindast, M., & Bina, P. (2009) · Pharmacology · doi:10.1159/000256666 · Cited by 40
Respiratory and Cognitive Subtypes of Panic: Preliminary Validation of Ley’s Model
Moynihan, J. E., & Gevirtz, R. (2001) · Behavior Modification · doi:10.1177/0145445501254005 · Cited by 34
“, Cowley et al., 1995). Yet, there are concerns about addiction with persistent use. And it is not clear that medication is the best course of intervention for compensated hyperventilators. Research has shown that chronic hyperventilators can restore their ETCO2 levels to normal or near normal within a matter of month…”
BackgroundInfluentialMemory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use
Deckersbach, T., Moshier, S. J., Tuschen‐Caffier, B., & Otto, M. W. (2011) · Depression and Anxiety · doi:10.1002/da.20891 · Cited by 33
“Furthermore, based on previous research which found no differences in neurocognitive performance between benzodiazepine-medicated and nonmedicated GAD and PD patients,[7,19] we hypothesized that long-term benzodiazepine-medicated PD patients would perform similarly to PD patients without longterm benzodiazepine use on…”
BackgroundTanay, V.-M., Greenshaw, A. J., Baker, G. B., & Bateson, A. N. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000879 · Cited by 28
Skelton, K. H., Gutman, D. A., Thrivikraman, K. V., Nemeroff, C. B., & Owens, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0713-3 · Cited by 28
“They produce a number of effects that oppose those of CRF, including suppression of HPA axis activation (Krulik and Cerny 1971; Kalogeras et al. 1990; Rohrer et al. 1994; Cowley et al. 1995), attenuation of stressinduced CRF transcription and release (Imaki et al.”
BackgroundSelf-citationCéspedes, I. C., de Oliveira, A. R., da Silva, J. M., da Silva, A. V., Sita, L. V., & Bittencourt, J. C. (2010) · Peptides · doi:10.1016/j.peptides.2010.08.022 · Cited by 26
Manthey, L., Giltay, E. J., van Veen, T., Neven, A. K., Vreeburg, S. A., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181d41f41 · Cited by 26
Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls
Roy‐Byrne, P., Cowley, D. S., Hommer, D. W., Greenblatt, D. J., Kramer, G. L., & Petty, F. (1992) · Psychopharmacology · doi:10.1007/bf02245493 · Cited by 24
Self-citationSkelton, K. H., Nemeroff, C. B., & Owens, M. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1737-04.2004 · Cited by 23
“…effects opposite to those of CRF, including suppression of HPA axis activation (Krulik and Cerny, 1971; Kalogeras et al., 1990; Rohrer et al., 1994, Cowley et al., 1995), as well as to directly antagonize stress-induced CRF transcription and release (Imaki et al., 1995; Pich et al., 1995), and the…”
Self-citationPomara, N., Willoughby, L. M., Ritchie, J., Sidtis, J. J., Greenblatt, D. J., & Nemeroff, C. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300365 · Cited by 20
“Cowley et al (1995) examined the effects of an acute challenge of diazepam in a group of panic disorder patients on chronic treatment with alprazolam compared to a group that was drug-naive with respect to the use of BZPs.”
BackgroundSelf-citationKroboth, P. D., Folan, M. M., Bauer, K. S., Tullock, W. C., Wright, C. E., & Sweeney, J. A. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04433.x · Cited by 17
Assessment of GABA A benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines
Potokar, J. P., Coupland, N., Wilson, S. J., Rich, A., & Nutt, D. (1999) · Psychopharmacology · doi:10.1007/s002130051104 · Cited by 16
The Place of Selective Serotonin Reuptake Inhibitors in the Treatment of Panic Disorder
DeVane, C. L. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03711.x · Cited by 16
Duke, A. N., Platt, D. M., & Rowlett, J. K. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05447-1 · Cited by 10
Memory and the septo-hippocampal system
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0008 · Cited by 10
A theory of the septo-hippocampal system
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0010 · Cited by 8
Assessment of GABAABenzodiazepine Receptor (GBzR) Sensitivity in Patients with Alcohol Dependence
Taylor, C., Nash, J. R., Rich, A. S., Lingford-Hughes, A. R., Nutt, D., & Potokar, J. P. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn056 · Cited by 8
Neurobiology of Anxiety and Panic
Coupland, N. J., & Nutt, D. (1995) · Neuroscience intelligence unit · doi:10.1007/978-3-662-21705-4_1 · Cited by 7
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0002 · Cited by 7
A theory of the behavioural inhibition system
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0005 · Cited by 6
Bigued, Taïwé, G. S., Njapdounké, J. S. K., Ngaibi, J., Nguezeye, Y., Sidiki, N., & Bum, E. N. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.14.3.0078 · Cited by 5
“A lot of evidences of the central GABAergic system have been demonstrated that certain patients suffering from anxiety were less sedate after administration of curative dose of benzodiazepine, indication a severe deterioration of the efficacy and sensitivity of the central complex GABAA receptors at the benzodiazepine…”
BackgroundSaccadic Eye Velocity after Selective GABAergic Treatment with Tiagabine in Healthy Volunteers
Zwanzger, P., Schüle, C., Eser, D., Baghai, T. C., Padberg, F., Ella, R., Möller, H., Rupprecht, R., & Kathmann, N. (2005) · Neuropsychobiology · doi:10.1159/000087845 · Cited by 5
Mother–Infant Touch, Neurochemistry, and Postpartum Anxiety
Lonstein, J. S., & Miller, S. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374285-8.00010-x · Cited by 5
Altered GABAA receptor function in women with endometriosis: a possible pain‐related mechanism
Sandström, A., Bixo, M., Bäckström, T. C., Möller, A., & Türkmen, Ş. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14559 · Cited by 4
Antiepileptic Drugs in the Treatment of Anxiety Disorders: Role in Therapy
Ameringen, M. V., Mancini, C., Patterson, B. A., & Truong, C. (2008) · Medical psychiatry · doi:10.3109/9780849382666.012 · Cited by 4
Klinisch-Neuropsychologische Aspekte der Therapie mit Psychopharmaka
Brunnauer, A., & Laux, G. (2010) · Springer eBooks · doi:10.1007/978-3-540-72340-0_25 · Cited by 3
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0006 · Cited by 3
Céspedes, I. C. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2007.tde-15012008-154514 · Cited by 3
Benzodiazepine discontinuation treatment in outpatients with complicated dependence
Vorma, H. (2003) · Työväentutkimus Vuosikirja · Cited by 3
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0012 · Cited by 2
Chattopadhyay, A., Darbar, S., Saha, S., & Karmakar, P. (2019) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.53.1.17 · Cited by 2
Biological behavior of 1,4-benzodiazepines and 1,4-benzothiazepines
Zamani, F., Zamani, N., Suzuki, T., & Doustkhah, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824516-3.00010-0 · Cited by 2
Putting Humpty Dumpty together again: the anxious personality and its inheritance
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0012 · Cited by 2
Roszkowski, S. C., Babalonis, S. L., Coe, M. A., Nuzzo, P. A., Lofwall, M. R., Fanucchi, L. C., & WALSH, S. L. (2024) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000746 · Cited by 1
PSYCHOPHARMOCOTHERAPY FOR PHOBIC AND OBSESSIVE-COMPULSIVE DISORDERSIN SCHIZOPHRENIA SPECTRUM STATES
Pavlichenko, A. V., Kessel'man, L. G., Pavlichenko, A. V., & Kessel'man, L. G. (2009) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2009-56 · Cited by 1
Fundamentals of the septo-hippocampal system
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0009 · Cited by 1
ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE
Fonyakin, A. V., & Гераскина, Л. А. (2009) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2009-57 · Cited by 1
Rohrig, T. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815163-1.00015-0 · Cited by 1
Brunnauer, A., Kapfhammer, H., Kissling, W., Bäuml, J., & Hamann, J. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_4 · Cited by 1
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0001 · Cited by 1
Memory and the septo-hippocampal system
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0008 · Cited by 1
Abuse and Dependence Liability of GABAA-Receptor Modulators
Rowlett, J. K., Duke, A. N., & Platt, D. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-465-0_7 · Cited by 1
“In humans, for example, tolerance develops rapidly to sedative effects and motor coordination deficits, whereas tolerance does not always develop to the anxiolytic or memory impairing effects of benzodiazepine-type drugs after long periods of use (23, 73 ,74).”
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0007 · Cited by 1
Impact of DHEA on GABA-agonist Challenge in Healthy Young and Older adults
Folan, M. M. (2003) · D-Scholarship@Pitt (University of Pittsburgh)
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0004
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0003
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0013
Symptoms and syndromes of anxiety
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0011
Estudio del mecanismo de regulación de la estructura y función del receptor GABAA
Ferreri, M. C. (2016) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/53808
Gray, J. A., & McNaughton, N. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.003.0001
(2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.002.0003
Preface to the paperback edition
(2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.002.0006
(2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.002.0005
(2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.002.0007
(2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198522713.002.0008
What do hippocampal cell fields represent?
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0007
The neurology of anxiety—planning circuits
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0011
A theory of the septo-hippocampal system (SHS)
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0010
Symptoms and syndromes of anxiety
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0013
The neurology of anxiety—survival circuits
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0006
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0002
The treatment of anxiety and fear disorders
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0014
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.002.0011
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0015
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.002.0009
The anxiolytic drugs—our key tool
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0004
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0003
List of online appendices and reviews
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.002.0010
A conceptual theory of the goal inhibition system
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.003.0005
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.002.0006
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.002.0004
McNaughton, N., & Gray, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780198843313.002.0005
Metadata
- Authors
- Cowley, D. S., Roy-Byrne, P. P., Radant, A., Ritchie, J. C., Greenblatt, D. J., Nemeroff, C. B., & Hommer, D. W.
- Affiliations
- University of Washington (US)
- United States Department of Veterans Affairs (US)
- Duke University (US)
- Tufts Medical Center (US)
- Venue
- Neuropsychopharmacology
- Published
- 1995-04
- Volume
- 12
- Issue
- 2
- Pages
- 147-157
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W1981896361
- Cited by
- 87
- References
- 52
- Citations by year
- 2024: 22 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2016: 1 · 2015: 3 · 2012: 1
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29mh043449-02, 5r29aa008161-05, 5r01mh049413-02)
- National Institute on Alcohol Abuse and Alcoholism (AA08161)
- National Institute of Mental Health (MH43449, MH-49413)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- panic disorder, alprazolam, benzodiazepine tolerance, diazepam, saccades, growth hormone secretion, short-term memory, plasma cortisol, sedation, phobic avoidance, disease severity, benzodiazepine sensitivity
- MeSH terms
- Adult, Alprazolam, Diazepam, Dose-Response Relationship, Drug, Drug Tolerance, Female, Heart Rate, Humans, Hydrocortisone, Male, Memory, Short-Term, Receptors, GABA-A, Saccades, Growth Hormone, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.